Cellomatics BioSciences Ltd. remains a trusted partner in delivering pre-clinical in vitro data in areas of common medical interest including Oncology, Immuno-oncology, Immunology, Inflammation and Respiratory. Our ability to provide high quality data to respected clients is a recognized asset of the company which we uphold by maintaining an updated repertoire of our in-house scientific equipment.
Cellomatics BioSciences Ltd. has recently invested in two equipments, The ImageXpress® Pico Automated Cell Imaging System and 2020 Attune NxT Flow Cytometer, to cater to the experimental needs of our expanding client network.
The ImageXpress® Pico Automated Cell Imaging System offers a powerful high-resolution imaging platform, accompanied by an array of analytical functionalities. The machine’s automated system captures both brightfield and fluorescent channels using pre-configured protocols thus minimising on set-up time and enabling experiments to run quickly. The imaging process itself is non-invasive and it occurs within a controlled cell culture environment.
Practical applications of the ImageXpress Pico Automated Cell Imaging System, as featured by the developers:
- Apoptosis analysis
- Cancer research
- Cell counting
- Infectious disease research
- Digital confocal
- Live cell imaging
- Neurite outgrowth/tracing
- Stem cell research
The research team’s increased feasibility to produce flow cytometry data was realised following the acquisition of the 2020 Attune NxT Flow Cytometer. This technology provides a robust, high performance workflow which operates on a user-friendly interface whose use is suitable for experts and beginners alike. This device has been developed to accommodate various sample types and be processed in a swift but accurate manner.
Practical applications of the 2020 Attune NxT Flow Cytometer, as featured by the developers:
- Suitable for samples such as large cell aggregates, low cell density and precious samples
- No-wash, no-lyse applications
- Fluorescent protein detection
- Stem cells
- Cell health
With these newest company investments, we aim to strengthen our expertise for most molecular cell biology needs and cement our reputation as a steadfast scientific organisation.